Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world
The drug has proven effective in patients with psoriasis, COVID-19 and lupus nephritis, inside and outside Cuba.
The drug has proven effective in patients with psoriasis, COVID-19 and lupus nephritis, inside and outside Cuba.
Combiovent, a Cuban lung ventilator for intensive care of adults is already “in the introduction phase” in the national health ...
The Cuban physicist, recently selected as editor of two U.S. magazines, values the reality of scientific research on the island ...
Patients with this and other inflammatory and autoimmune diseases could benefit from the novel drug developed by Cuban biotechnology.
Created by scientists from the University of Oriente, these prostheses have “electromyographic sensors to capture signals from the remaining muscles,” ...
The listing comes from the AD Scientific Index, a global measurement and analysis system that shows the coefficients of total ...
The developers of the drug assure that the objective is to decrease the viral load of the dengue virus so ...
Scientists and directors of the Roswell Park Institute, based in New York City, spoke in the island about their relationship ...
The creators of Curmeric have already requested a patent application for the drug
The Soberana 01, Soberana 02, Abdala and Mambisa vaccines were chosen to receive the Medal for Inventors awarded by that ...
Saint Vincent is the first country in the Caribbean Community (CARICOM) to authorize the use of the Cuban drug, which ...
The drug is the result of studies carried out by the Center for Molecular Immunology (CIM) in collaboration with other ...
The drug was developed by the enterprise Laboratorios AICA in conjunction with the Ministry of Public Health (MINSAP), based on ...
The financing will come through a donation from the Franco-Cuban Equity Fund and its first outlay this year will make ...
During the meeting, the first to be held with representatives of the WHO and PAHO to address the approval of ...
According to the MINSAP, to date 3,491,529 people have received at least one dose of one of the Cuban vaccine ...
This figure is higher than that established by the World Health Organization (WHO) to consider SARS-CoV-2 immunogens as effective vaccines.
The deputy director of the Development and Production of Diagnostic Kits area, Irina Valdivia, stated that the test, registered by ...
Rosalía Abreu came to take care of more than 200 primates of 40 species and other animals brought from different ...
The principal investigator of the clinical trials, Arturo Chang, pointed out that as part of the studies, the levels of ...
However, Cuban specialists aspire to higher figures, as confirmed by the Director of Clinical Research at the Center for Genetic ...
The immunization process is being carried out in 44 sites located in the province’s 13 municipalities.
Francisco Hernández, head of the clinical study, explained that at this stage “there will be a follow-up of all volunteers ...
The head of the National Department of Primary Health Care of the MINSAP, María Elena Soto, explained that the vaccination ...
Some 100,000 doses arrived in Tehran in March for the testing. Last Saturday, Soberana 02 obtained permission for clinical trials ...
OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.